• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病(NAFLD)患者的实验室指标:非酒精性脂肪性肝病患者与无肝脂肪变性的肥胖患者的比较。

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis.

作者信息

Bernhardt Philipp, Kratzer Wolfgang, Schmidberger Julian, Graeter Tilmann, Gruener Beate

机构信息

Department of Internal Medicine I, Ulm University Hospital, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

Department of Diagnostic and Interventional Radiology, Ulm University Hospital, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

出版信息

BMC Res Notes. 2018 Feb 6;11(1):101. doi: 10.1186/s13104-018-3212-1.

DOI:10.1186/s13104-018-3212-1
PMID:29409538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5801753/
Abstract

OBJECTIVE

Search for meaningful laboratory and anthropometric parameters in lean non-alcoholic fatty liver disease (lean NAFLD) in the general population. Out of 2445 subjects in a random population sample, we compared those who had a body mass index (BMI) < 25 and a fatty liver [lean NAFLD (LN), n = 5] with obese subjects who had a BMI > 30 but no fatty liver [non-NAFLD (NN), n = 27] in a follow-up examination. Ultrasonic, anthropometric and laboratory parameters were collected.

RESULTS

There were significant differences (p < 0.05) between the LN and the NN groups with respect to serum ferritin (199.2 ± 72.1 LN vs 106.0 ± 89.6 NN), haemoglobin (14.9 ± 0.8 LN vs 13.5 ± 1.2 NN), haematocrit (0.438 ± 0.019 LN vs 0.407 ± 0.035 NN) and Mean corpuscular haemoglobin concentration (34 ± 0.6 LN vs 33.2 ± 0.8 NN). Significantly lower values of soluble transferrin receptor were measured in the LN group (2.8 ± 0.4 LN vs 3.8 ± 1.5 NN). In both groups, the measured HOMA-IR index (homeostatic model assessment of insulin resistance index) (2.3; normal range ≤ 1) was abnormal. Mean cholesterol (6.2 ± 1.4 LN and 5.6 ± 1.1 NN) and low-density lipoprotein levels (3.8 ± 1.0 LN 3.4 ± 0.9 NN) were above the upper limit of normal in both groups, as was the mean triglycerides level in the LN group (2.6 ± 2.0). In summary, there are differences in parameters of iron and fat metabolism between subjects with LN and overweight subjects without fatty liver infiltration.

摘要

目的

在普通人群的瘦型非酒精性脂肪性肝病(瘦型NAFLD)中寻找有意义的实验室和人体测量学参数。在一个随机人群样本的2445名受试者中,我们在一次随访检查中,将体重指数(BMI)<25且患有脂肪肝的受试者[瘦型NAFLD(LN),n = 5]与BMI>30但无脂肪肝的肥胖受试者[非NAFLD(NN),n = 27]进行了比较。收集了超声、人体测量学和实验室参数。

结果

LN组和NN组在血清铁蛋白(LN组为199.2±72.1,NN组为106.0±89.6)、血红蛋白(LN组为14.9±0.8,NN组为13.5±1.2)、血细胞比容(LN组为0.438±0.019,NN组为0.407±0.035)和平均红细胞血红蛋白浓度(LN组为34±0.6,NN组为33.2±0.8)方面存在显著差异(p<0.05)。LN组可溶性转铁蛋白受体的值显著较低(LN组为2.8±0.4,NN组为3.8±1.5)。两组中测得的HOMA-IR指数(胰岛素抵抗稳态模型评估指数)(2.3;正常范围≤1)均异常。两组的平均胆固醇(LN组为6.2±1.4,NN组为5.6±1.1)和低密度脂蛋白水平(LN组为3.8±1.0,NN组为3.4±0.9)均高于正常上限,LN组的平均甘油三酯水平(2.6±2.0)也是如此。总之,瘦型NAFLD受试者与无脂肪肝浸润的超重受试者在铁和脂肪代谢参数方面存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/5801753/e47003bd25cd/13104_2018_3212_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/5801753/9d964cd9df20/13104_2018_3212_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/5801753/e47003bd25cd/13104_2018_3212_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/5801753/9d964cd9df20/13104_2018_3212_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93bb/5801753/e47003bd25cd/13104_2018_3212_Fig2_HTML.jpg

相似文献

1
Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis.非酒精性脂肪性肝病(NAFLD)患者的实验室指标:非酒精性脂肪性肝病患者与无肝脂肪变性的肥胖患者的比较。
BMC Res Notes. 2018 Feb 6;11(1):101. doi: 10.1186/s13104-018-3212-1.
2
Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver.血红蛋白联合甘油三酯和铁蛋白预测非酒精性脂肪肝
J Gastroenterol Hepatol. 2014;29(7):1508-14. doi: 10.1111/jgh.12580.
3
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
4
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
5
Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.非酒精性脂肪性肝病肥胖儿童的颈动脉内膜中层厚度及血流介导的血管舒张功能
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:92-8. doi: 10.5152/tjg.2014.5552.
6
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
7
Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease.低 25-羟维生素 D 水平与非酒精性脂肪性肝病肥胖青少年的胰岛素敏感性相关。
Obes Res Clin Pract. 2013 Jul-Aug;7(4):e275-83. doi: 10.1016/j.orcp.2012.01.004.
8
Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.血糖正常患者血清同型半胱氨酸与非酒精性脂肪性肝病的临床研究
Med Sci Monit. 2016 Nov 2;22:4146-4151. doi: 10.12659/msm.897924.
9
Study and Comparison of Metabolic Profile of Lean and Obese Subjects with Non Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的瘦素和肥胖受试者代谢谱的研究与比较
J Assoc Physicians India. 2020 Aug;68(8):51-54.
10
Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.血清三酰甘油/高密度脂蛋白胆固醇比值与儿童和青少年颈动脉内膜中层厚度、胰岛素抵抗和非酒精性脂肪肝的关系。
Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):737-43. doi: 10.1016/j.numecd.2014.01.010. Epub 2014 Jan 29.

引用本文的文献

1
Causal associations of single anthropometric measures and body shape with nonalcoholic fatty liver disease: A Mendelian randomization study.单一人体测量指标和体型与非酒精性脂肪性肝病的因果关联:一项孟德尔随机化研究
Medicine (Baltimore). 2025 Jul 4;104(27):e43108. doi: 10.1097/MD.0000000000043108.
2
Association of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease and hepatic steatosis in United States adults: insights from NHANES 2017-2020.美国成年人中非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与非酒精性脂肪性肝病及肝脂肪变性的关联:来自2017 - 2020年美国国家健康与营养检查调查(NHANES)的见解
Front Nutr. 2025 Apr 11;12:1540903. doi: 10.3389/fnut.2025.1540903. eCollection 2025.
3

本文引用的文献

1
Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.系统评价与荟萃分析:非酒精性脂肪性肝病的危险因素表明,瘦型和肥胖型患者存在共同的代谢和心血管特征改变。
Aliment Pharmacol Ther. 2017 Jul;46(2):85-95. doi: 10.1111/apt.14112. Epub 2017 May 2.
2
Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes?社论:“瘦型”非酒精性脂肪性肝病:BMI正常的代谢性肥胖……与基因有关吗?
Am J Gastroenterol. 2017 Jan;112(1):111-113. doi: 10.1038/ajg.2016.527.
3
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver.
The Regulatory Impact of CFLAR Methylation Modification on Liver Lipid Metabolism.CFLAR 甲基化修饰对肝脏脂质代谢的调控影响。
Int J Mol Sci. 2024 Jul 19;25(14):7897. doi: 10.3390/ijms25147897.
4
Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease.瘦型非酒精性脂肪性肝病的临床特征和蛋白质组学特征。
Front Endocrinol (Lausanne). 2023 Nov 16;14:1171397. doi: 10.3389/fendo.2023.1171397. eCollection 2023.
5
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者临床评估与管理的TASL实践指南。
Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023.
6
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines.非酒精性脂肪性肝病(NAFLD)与精神疾病:情绪、代谢和药物之间的联系机制
Front Neurosci. 2022 Nov 15;16:1042442. doi: 10.3389/fnins.2022.1042442. eCollection 2022.
7
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.AGA 临床实践更新:瘦个体中非酒精性脂肪性肝病的诊断和管理:专家评论。
Gastroenterology. 2022 Sep;163(3):764-774.e1. doi: 10.1053/j.gastro.2022.06.023. Epub 2022 Jul 14.
8
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.代谢相关脂肪性肝病(MAFLD):一种超越肝脏的多系统疾病。
J Clin Transl Hepatol. 2022 Apr 28;10(2):329-338. doi: 10.14218/JCTH.2021.00178. Epub 2021 Oct 19.
9
NAFLD in normal weight individuals.正常体重个体中的非酒精性脂肪性肝病
Diabetol Metab Syndr. 2022 Mar 24;14(1):45. doi: 10.1186/s13098-022-00814-z.
10
The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study.非酒精性单纯性脂肪肝患者发生心脏代谢紊乱的风险:一项纵向研究
Am J Prev Cardiol. 2020 Oct 20;4:100097. doi: 10.1016/j.ajpc.2020.100097. eCollection 2020 Dec.
铁调素表达缺失可减轻肝脏脂肪变性并导致肝纤维化。
World J Hepatol. 2016 Feb 8;8(4):211-25. doi: 10.4254/wjh.v8.i4.211.
4
Iron and the liver.铁与肝脏
Liver Int. 2016 Jan;36 Suppl 1:116-23. doi: 10.1111/liv.13020.
5
Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study.HOMA-IR和QUICKI在代谢综合征及非酒精性脂肪性肝病诊断中的最佳切点:一项基于人群的研究。
J Diabetes Complications. 2016 Mar;30(2):269-74. doi: 10.1016/j.jdiacomp.2015.11.019. Epub 2015 Dec 2.
6
Ironing out Ferroportin.解决铁转运蛋白问题
Cell Metab. 2015 Nov 3;22(5):777-87. doi: 10.1016/j.cmet.2015.09.006. Epub 2015 Oct 1.
7
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.非酒精性脂肪性肝病瘦患者的特征:高血红蛋白水平的潜在作用。
Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.
8
Factors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study.2型糖尿病中与β细胞功能障碍相关的因素:BETADECLINE研究
PLoS One. 2014 Oct 27;9(10):e109702. doi: 10.1371/journal.pone.0109702. eCollection 2014.
9
The association between hematological parameters and insulin resistance is modified by body mass index - results from the North-East Italy MoMa population study.血液学参数与胰岛素抵抗之间的关联受体重指数影响——来自意大利东北部MoMa人群研究的结果
PLoS One. 2014 Jul 7;9(7):e101590. doi: 10.1371/journal.pone.0101590. eCollection 2014.
10
Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man.血红素加氧酶-1 驱动小鼠和人类的代谢性炎症和胰岛素抵抗。
Cell. 2014 Jul 3;158(1):25-40. doi: 10.1016/j.cell.2014.04.043.